In our results, high expression of MMP1, CD24, SDC1, and SPP1 correlated to the development of breast cancer, worse OS and immune cell infiltration, indicating that MMP1, CD24, SDC1, and SPP1 might be as the potential prognostic biomarkers and immunotherapy targets for breast tumor. The gene discussed is SPP1; the disease is breast carcinoma.